Joseph Cappello Genelux Corp (GNLX) insider trading activity

Shares Held (Direct Ownership) 52.3K

8.31% 3M change

149.44% 12M change

Total Value Held N/A

Joseph Cappello Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 12 2025	SELL Open market or private sale	$13,832 $2.92 p/Share	4,737 Reduced 8.31%	52,266 Common Stock
Mar 14 2025	BUY Grant, award, or other acquisition	-	13,350 Added 18.98%	57,003 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	-	29,000 Added 39.92%	43,653 Common Stock
Dec 16 2024	SELL Open market or private sale	$14,742 $2.34 p/Share	6,300 Reduced 30.07%	14,653 Common Stock
Mar 14 2024	BUY Grant, award, or other acquisition	-	11,557 Added 35.55%	20,953 Common Stock
Feb 19 2024	BUY Grant, award, or other acquisition	-	3,661 Added 28.04%	9,396 Common Stock
Aug 18 2023	SELL Open market or private sale	$77,478 $23.73 p/Share	3,265 Reduced 36.28%	5,735 Common Stock
Feb 17 2023	BUY Grant, award, or other acquisition	-	9,000 Added 50.0%	9,000 Common Stock

VP, Pharmaceutical Development

Westlake Village, CA

Receive a notification when an Institution or Guru buys or sells GNLX shares.

Notify only if

Value

Get notified when an Genelux Corp insider buys or sells GNLX shares.

Notify only if

Operation

Value

Type

Receive news related to GENELUX CORP